Ani pharmaceuticals to participate at the h.c. wainwright 3rd annual bioconnect conference at nasdaq

Princeton, n.j., may 12, 2025 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that nikhil lalwani, chief executive officer, and stephen carey, chief financial officer, will present at the h.c. wainwright 3rd annual bioconnect investor conference at nasdaq as follows:
ANIP Ratings Summary
ANIP Quant Ranking